Details.
Medical treatment with dupilumab for moderate to severe atopic dermatitis, including eczema, and severe asthma in Australia. Dupilumab is administered by subcutaneous injection using a pre-filled syringe, initially every 2 weeks. Further dosing and frequency may be changed by your doctor depending on your condition and response to treatment. Clinic nurses or your GP can provide guidance with self-injection or administer the injection. Treatment duration depends on effectiveness and tolerability. Regular follow-up appointments are important to monitor response and potential side effects.
